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Abstract
Objectives: The investigation centers on whether there is a reperfusion-induced specific cardiac inflammatory reaction after bypass
surgery. Background: Cardiopulmonary bypass (CPB) leads to systemic inflammation. Additionally, cardiac inflammation due to
reperfusion could occur. Knowledge about nature and time course of this reaction might help to develop cardioprotective interventions.
Methods: In 12 patients receiving coronary bypass grafts, arterial and coronary venous blood was obtained before onset of CPB, and 1, 5,
10, 25, 35 and 75 min after cardiac reperfusion. Plasma levels of IL6 and IL8 were measured by immunoassay. CD11b, CD41, and CD62
on blood cells were quantified by flow cytometry. Measurement of CD41, a platelet marker, on neutrophils and monocytes allowed
detection of leukocyte–platelet microaggregates. Results: Transcardiac veno–arterial difference of IL6 rose in the 10th and 25th min of
reperfusion (from 0 to 7 pg/ml; p,0.05), and after 75 min (15 pg/ml). IL8 did not change. CD11b on neutrophils (PMN) decreased
transcardially to 95, 88 and 82% of the initial level in the 5th, 10th, and 75th min, respectively, suggesting sequestration of activated
neutrophils. CD62 on platelets rose about 30% in the 75th min. Initially, leukocyte–platelet microaggregates were formed during coronary
passage (131% of the arterial level for PMN, 123% for monocytes). During reperfusion, coaggregates were retained (PMN: 21% and
27% in the 5th and 10th min, monocytes: 222%, 213% and 212% in the 1st, 5th and 10th min. Conclusions: During early reperfusion
after aortic declamping, the coronary bed is already a source of proinflammatory stimuli and target for activated leukocytes, partly in
conjunction with platelets. Mitigation of these phenomena might help to improve cardiac function after CPB especially in patients at risk.
Ó 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction solutions [7]. However, the possible role of the heart as a
source of inflammatory stimuli and as a target of inflam-
Numerous experimental and clinical studies have dem- mation in the clinical situation of CPB is less well
onstrated that cardiopulmonary bypass (CPB) leads to a characterized. This could be relevant, because after aortic
systemic inflammatory response, characterized by activa- declamping global cardiac reperfusion occurs, and reperfu-
tion of neutrophils [1] and platelets [2], formation of sion, as such, represents a massive proinflammatory
leukocyte–platelet coaggregates [3,4], and elevation of stimulus in the heart [8,9]. In turn, different features of
cytokine plasma levels [5]. The main reasons for this inflammation depress cardiac performance: intracoronary
generalized inflammation are the contact of blood with retention and activation of neutrophils represents a main
artificial surfaces in components of the extracorporeal aspect of reperfusion injury [11], while some cytokines
circulation apparatus [6,7], and the influence of priming have direct negative inotropic effects [10]. Consequences
of reperfusion injury, such as myocardial stunning and
coronary low-reflow, might, thus, infringe the clinical*Corresponding author. Tel.: 149-89-5996-401; Fax: 149-8142-9345;
E-mail: s.zahler@lrz.uni-muenchen.de
1See pages 511–513. Time for primary review 26 days.
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Table 1benefit of interventions employing extracorporeal circula-
aClinical characteristics and pre-medication of the study patientstion and clamping of the aorta. Indeed, antiinflammatory
Age 6462 yearsmedication [12] and removal of leukocytes from the
Sex 3 women, 9 mencirculation [13] seem to have beneficial effects on car-
Ejection fraction 6763%diovascular function after CPB. Duration of ischemia (min) 5265
Transcardiac inflammation has already been described in Time to reperfusion of grafts (min) 2662
some clinical situations of reperfusion, particularly balloon Number of distal anastomoses 3.160.2
Number of proximal anastomoses 1.860.1angioplasty under stable [14] or post-infarction conditions
Diabetes 3[9]. There even seems to be a causal link between acute
Aspirin 12inflammatory responses during reperfusion (formation of Nitrates 11
leukocyte–platelet aggregates) and the occurrence of re- Beta-blockers 10
stenosis [14]. In the present study, we investigated in- Diuretics 3
ACE-inhibitors 5flammatory reactions in blood during coronary passage in
apatients undergoing coronary artery bypass grafting, both Numerical values are means6S.E.M.
before extracorporeal circulation and after the 1st, 5th,
10th, 25th, 35th and 75th min of reperfusion after aortic
declamping. In detail, we analyzed plasma levels of
cytokines (IL6 and IL8) and activation markers on 2.3. Blood samples
leukocytes (CD11b, a subunit of the adhesion molecule
Mac-1) and platelets (CD41, a subunit of the GPIIb / IIIa Blood samples (3 ml each) were drawn simultaneously
receptor, and CD62, i.e. P-selectin), and determined the from the cannulated radial artery and from the coronary
percentage of platelet-carrying leukocytes in systemic sinus catheter: before administration of heparin, after the
arterial and coronary venous blood. Furthermore, trans- 1st, 5th and 10th min after release of the aortic cross
coronary differences of the soluble form of the adhesion clamp, as well as after release of the Lambert–Kay clamp
molecule ICAM-1, and of leukocyte- and platelet-counts (about 25th min of reperfusion), after application of
were measured. protamine (about 35th min), and after 75 min of reperfu-
sion. A multi-purpose catheter with a 5-cm tip (708 angle)
was used for blood sampling. The dead space of the
catheter being about 1 ml, the first 5 ml of every sample
2. Methods were discarded. The correct transcutaneous emplacement
of the coronary sinus catheter was monitored by observing
2.1. Patients the pressure curve of the catheter and by measuring
oxygen saturation of the blood samples. The pressure
12 patients, ,75 years old, undergoing elective coronary curves had to show a venous pattern throughout, and
artery bypass graft surgery and with an ejection fraction oxygen saturation had to be in the range of 25–40% for
.55% entered the study, which was approved by our inclusion of the samples in the study.
institutional ethics committee. The study was performed
according to the latest amendment of the Declaration of
Helsinki. All patients gave their written informed consent 2.4. Immunoassays
for inclusion in the study. Exclusion criteria were myocar-
dial infarction within 14 days before the operation, in- Immediately after sampling, an aliquot of the blood (2
flammatory diseases or intake of immunosuppressants. The ml) was stored on ice until centrifugation at 2000 g for 10
clinical characteristics of the study patients are summa- min to obtain platelet poor plasma. This was stored at
rized in Table 1. 2208C until final processing. Concentrations of IL6 and
IL8 were determined by sandwich type immunoassays
(Endogen). In both cases standards covered a range from 0
2.2. Anesthesia and surgery to 1000 pg/ml.
Soluble ICAM-1 was also measured by ELISA (T Cell
The patients were anaesthetized with either sufentanil1 Diagnostics). In this case samples had to be diluted 1:100
midazolam, sufentanil1propofol, or remifentanil1 to reach the optimum sensitivity of the assay (0.3 ng/ml).
midazolam; no volatile anaesthetics were used. Oxygen- Due to continuous hemodilution during the surgical
ation of the blood was performed with bubble oxygenators intervention, all measured concentrations had to be cor-
(Dideco, Mirandola, Italy). After initiation of extracorpore- rected to the hematocrit of the arterial pre-heparin sample
al circulation, the blood was cooled to 26–288C (moderate to ensure their comparability. Coronary veno–arterial
hypothermia). A 1000-ml volume of cold Bretschneider differences of IL6, IL8 and ICAM-1 were calculated for
Ò
solution (custodiol ) was used for antegrade cardioplegia. each time point.
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2.5. Flow cytometry value. A difference was considered as statistically signifi-
cant if p,0.05.
For flow cytometry, 100-ml aliquots of the blood
samples were immediately mixed with 1 ml FACS lysing
solution (Becton Dickinson). This ensured simultaneous 3. Resultsfixation of leukocytes and lysis of red blood cells. For
analysis of platelets, 1 ml Cellfix (Becton Dickinson) was 3.1. Cytokine measurements
employed instead.
Leukocytes were pelleted for 5 min at 200 g, washed The arterial levels of IL6 rose continuously, from ,0.1
with Cellwash (Becton Dickinson), pelleted again, and pg/ml before the intervention, to 110 pg/ml after 75 min
then double-stained with phycoerythrin (PE) conjugated
of reperfusion (Fig. 1A). Under basal conditions, there was
anti-CD11b antibodies (Exalpha) and with FITC labelled
no transcardiac concentration difference of IL6. In the 10th
anti-CD41 antibodies (Serotec). The measurement of the
and 25th min of reperfusion, however, significant veno–platelet marker CD41 on leukocytes served to determine
arterial differences of IL6 (7 pg/ml) were to be detected.
the percentage of neutrophils and monocytes carrying This increase of IL-6 concentration rose further to about 15platelets. After incubation with the antibodies for 15 min pg/ml in the 75th min of reperfusion (Fig. 1B).in the dark, cells were washed, centrifuged and resuspend- The arterial content of IL8 was 8 pg/ml pre-operatively,
ed in Cellwash, prior to measurement.
and rose continuously until the 35th min of reperfusion (50For the analysis of platelets the fixed blood suspension pg/ml), i.e. up to the application of protamine. Arterial
was centrifuged at 1200 g for 5 min. The supernatant was IL8 then declined to 30 pg/ml in the 75th min (Fig. 1C).discarded and the pellet resuspended in 1 ml Cellwash. A There was no statistically significant coronary veno-arterial50-ml volume of this suspension was incubated with difference for IL8 at any time point (Fig. 1D).
antibodies against CD41 (FITC labelled, Serotec) and
CD62 (PE conjugated, Harlan Seralab) for 15 min in the
dark. Cells were then centrifuged at 1200 g for 5 min, 3.2. Expression of CD11b
washed with Cellwash, centrifuged again, finally resus-
pended in 500 ml Cellwash, and measured. On neutrophils, expression of CD11b in arterial samples
Flow cytometry was performed with a FACScan and rose to about 140% of the basal level in the 25th min of
Lysys II software (Becton Dickinson). Ten thousand reperfusion, then declined again to the initial level (Fig.
events were acquired for each sample. Neutrophils, mono- 2A). Monocytes showed a similar behaviour on a lower
cytes and platelets were discriminated by their characteris- level of activation (Fig. 2C). CD11b expression was lower
tic pattern of forward and sideward scatter, and separately on neutrophils emerging from the coronary system during
analysed after setting appropriate gates. The mean fluores- initial reperfusion (1st, 5th, 10th min) than the corre-
cence intensity was taken as a measure of antibody sponding arterial values, and then again during later
binding. Reproducibility was ensured by regular calibra- reperfusion (75th min, Fig. 2B). The early response of
tion of the flow cytometer. The non-specific background monocytes (1st, 5th, 10th min) was similar, but the v–a
was quantified by measurement of the fluorescence intensi- difference did not reach statistical significance (Fig. 2D).
ty of samples labelled with non-binding isotype matched
antibodies (mouse IgG1-PE from SBA, Birmingham, USA, 3.3. Soluble ICAM-1
and mouse IgG2a-FITC from Exalpha), and subsequently
subtracted. To check whether changes in CD11b detectability couldThe considerable variability of both leukocyte and
arise from masking of this molecule by different levels ofplatelet markers in the study population, even under basal its soluble ligand sICAM-1 in the plasma, we also mea-
conditions, made it necessary to normalize fluorescence
sured plasma levels of sICAM-1 during early reperfusion.intensities. The pre-interventional arterial value of each The basal arterial concentration of sICAM-1 was 200individual — termed basal in the following — was set as
ng/ml, and did not change significantly during the first100% for every flow cytometric parameter. All changes are
minutes of reperfusion (Fig. 3A). A coronary veno–arterial
therefore given in percentages. difference of sICAM-1 was detected in the 10th min of
reperfusion (20 pg/ml), but not at earlier time points (Fig.2.6. Statistical analysis 3B). The transcardiac rise in plasma levels at 10 min
amounted to about 10%.The given veno–arterial differences are means of in-
dividually calculated differences, and not differences of
mean values. All results are expressed as means6S.E.M. 3.4. Platelet activation markers
ANOVA for repeated measurements was applied for the
comparison of values at different time points with the basal The surface expression of both platelet activation
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Fig. 1. Arterial plasma levels of IL6 (A) and IL8 (C) at various times before, during, and after CPB and coronary veno–arterial differences of IL6 (B) and
IL8 (D). Values are means, bars represent S.E.M. * p,0.05 as compared to the initial value.
Fig. 2. Percentual changes of mean CD11b fluorescence on PMN (A) and monocytes (C) during and after CPB in arterial blood, and veno–arterial changes
of these values for PMN (B) and monocytes (D). Values are means6S.E.M., * p,0.05 vs. the initial value.
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markers, CD62 (P-selectin) and CD41 (gpIIb / IIIa), in-
creased rapidly on arterial platelets, with the maxima after
protamine administration in the 35th min of reperfusion
(Fig. 4A and C). Coronary passage led to neither a
significant loss nor upregulation of the two markers during
early reperfusion (Fig. 4B and D). However, a rise of
CD62 expression of 25% above baseline was observed in
the 75th min of reperfusion (Fig. 4B).
3.5. Leukocyte–platelet interaction
During the first 25 min of reperfusion, the occurrence of
neutrophil–platelet coaggregates in arterial blood (mea-
sured as percentage CD41 positive neutrophils) was mark-
edly elevated vs. the basal state before CPB and later time
points (Fig. 5A). The same was true for monocyte–platelet
coaggregates, however with a more protracted time course,
and on a much higher level, with up to 60% of the arterial
monocytes carrying platelets, as compared to maximally
15% for neutrophils (Fig. 5A and C). The coronary veno–
arterial difference of leukocyte–platelet microaggregates
was positive under basal conditions (Fig. 5B and D), i.e.,
new aggregates were being formed during coronary pas-
sage (31% increase vs. arterial values for PMN, 23%Fig. 3. Arterial plasma levels of soluble ICAM-1 (A) and coronary
increase for monocytes). During the first minutes ofveno–arterial differences of sICAM-1 (B) before CPB as well as 1, 5, and
10 min after aortic declamping. Values are means6S.E.M., * p,0.05 vs. reperfusion, as well as after 35 min (protamine infusion),
the initial value. the percentual coronary veno–arterial difference of both,
Fig. 4. Time course of the percentual mean fluorescence of CD62 (A) and CD41 (C) on platelets in arterial blood and percentual changes of fluorescence of
CD62 (B) and CD41 (D) during coronary passage. Values are means6S.E.M., * p,0.05 vs. initial value.
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Fig. 5. Upper panel: Percentage of PMN carrying platelets (CD41 positive PMN) (A) and monocytes carrying platelets (C) in the arterial blood before and
at various time points during and after CPB. Lower panel: changes of PMN carrying platelets (B) and monocytes carrying platelets (D) during coronary
passage as percent of the respective arterial value. Values are means6S.E.M., * p,0.05 vs. the initial value.
neutrophil– and monocyte–platelet aggregates, decreased 4. Discussion
significantly below these basal values (Fig. 5B and D). In
fact, less aggregates were emerging from the coronary The present study demonstrates that, after CPB, the
system than were entering it (negative v–a-difference). human heart is a site of postischemic inflammation and a
source of proinflammatory stimuli. Findings leading to this
3.6. Cell counts conclusion are (I) increase of IL6 concentrations after
coronary passage early in reperfusion, (II) trapping of
The time courses of the veno–arterial differences for CD11b positive leukocytes in the coronary system, and
leukocytes and platelets are given in Table 2. In the 1st (III) trapping of leukocyte /platelet aggregates in the
min of reperfusion, as well as immediately after reperfu- coronary bed during initial reperfusion. These effects occur
sion of the grafts (about 25th min), there was a tendencial in addition to the systemic inflammatory changes evoked
increase of both leukocyte and platelet counts during by the extracorporeal circulation.
coronary passage. At all other time points, leukocytes
tended to be retained in the coronary system. However, 4.1. Cytokines
statistically significant retention (Table 2) was attained
only after 35 min (platelets) and 75 min (leukocytes). A systemic increase of the cytokines IL6 and IL8 due to
extracorporeal circulation has already been reported by a
Table 2
aVeno–arterial differences of leukocyte- and platelet counts
Time of reperfusion (min) 1 5 10 25 35 75
Leukocytes 5776200 21096220 21446146 2286241 23436230 26886387*
Platelets 655063759 2357963351 605364501 178965547 211 00063424* 2133365290
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number of authors [1,5,15]. In our present study, we have minutes of reperfusion. This finding conflicts with the
found similar systemic increases of both IL6 and IL8 in the upregulation of CD11b (i.e. activation of PMN) observed
blood of patients undergoing cardiopulmonary bypass (Fig. during coronary passage after myocardial infarction and
1A and C). In addition to this systemic response, the PTCA [9]. Lower mean expression of CD11b could mean
cardiac production and release of cytokines might be of (A) deactivation of leukocytes, (B) masking of CD11b by
special interest, because cytokines act negatively inotropic binding of a soluble physiologic ligand, or (C) retention of
[10]. They could, thus, directly contribute to myocardial the most activated leukocytes in the reperfused coronary
stunning. Moreover, the cytokines produced by the heart system. Hypothesis (A) is very improbable, because no
itself could further locally upregulate coronary endothelial mechanism has been described for a rapid downregulation
adhesion molecules [16], leading to retention and activa- of CD11b (proteolytic shedding, as in the case of L-
tion of passing leukocytes, and generate a chemotactic selectin, does not seem to occur). To test the second
gradient for inflammatory cells into the cardiac paren- hypothesis (B), we measured transcardiac concentrations
chyma. Indeed, rapid cardiac release of the cytokines IL6 of soluble ICAM-1, a natural ligand for CD11b [22].
and IL8 has been shown in humans after myocardial However, after 5 min of reperfusion, when there already
infarction and subsequent recanalization, and has been was a notable decrease of CD11b, no enhanced veno–
interpreted as a sign of postischemic cardiac inflammation arterial differences of sICAM-1 were to be found (Fig.
[9]. In experimental models of cardiac ischemia and 3B). Interestingly, there was a significant rise of sICAM-1
reperfusion, the induction of IL6- and IL8-mRNA has been after 10 min of reperfusion. This may well be taken as a
demonstrated [8,17], and during pediatric CPB, the induc- sign of endothelial activation. To date, however, there is no
tion of IL8 in human heart muscle has been shown [18]. consensus on the pathophysiological significance of the
In our study we have, for the first time, measured presence of soluble adhesion molecules in plasma. With
coronary veno–arterial differences of IL6 and IL8 levels respect to explanation (C), an actual sign of leukocyte
during acute post-crossclamp reperfusion. Surprisingly, retention is the tendencially negative veno–arterial differ-
IL6 concentrations rose during coronary passage already ence of leukocyte counts at those time points, at which
after 10 and 25 min of reperfusion (Fig. 1B), a timepoint CD11b decreased most (Table 2). One has, however, to
much too early to allow de novo synthesis of a protein. keep in mind that leukocyte adhesion does not necessarily
The absence of this effect in the case of IL8 (Fig. 1D) depend on upregulation of surface CD11b, but can also be
suggests that it was no mere washout phenomenon after induced by an increase of CD11b affinity [23]. Thus, a
ischemia, but the specific increase of a proinflammatory strict correlation of CD11b expression and leukocyte
agent. Thus, it may be concluded that preformed IL6 has retention may not be expected.
been released from cardiac tissue, with cardiac endothelial The partial conflict of these results with previous data
cells or macrophages being the most likely sources. In [9] suggests that different clinical forms of myocardial
contrast to this early rise of IL6, the secondary increase ischemia and reperfusion (e.g. acute myocardial infarction
after 75 min might well be due to gene induction by and subsequent rescue PTCA as compared to cardioplegic
reperfusion [8]. global ischemia during cardiosurgery) might well result in
quite different extents and relations of leukocyte activation
and retention. The pathophysiological consequences have
4.2. Activation of leukocytes still to be evaluated.
Leukocytes, especially neutrophils (PMN), are widely
accepted as one of the main causes for reperfusion injury 4.3. Activation of platelets
[11]. After adhesion to endothelium, they are chemotacti-
cally activated, transmigrate through the endothelial barrier During reperfusion of previously ischemic myocardium,
and undergo a so-called ‘burst reaction’ [19], liberating activated platelets with their thrombotic potential are a risk
proteolytic enzymes and reactive oxygen species. These factor for restenosis [24]. Furthermore, anti-platelet drugs
processes cause microvascular leakage, vasoconstriction have turned out to be promising tools in the prevention of
and, ultimately, tissue damage [20]. Extracorporeal circula- reocclusion [25]. During CPB, marked activation of
tion leads to rapid upregulation of CD11b (1), an early platelets has been described [2]. In our study, we measured
activation marker on leukocytes and an adhesion molecule the surface expression of two activation markers on
which is important for the attachment of leukocytes to the platelets: the adhesion molecule CD62 or P-selectin, which
endothelium [21]. We, too, observed the systemic upregu- enables platelets to adhere to leukocytes [26], and CD41, a
lation of CD11b on both PMN and monocytes during CPB subunit of the integrin GPIIb / IIIa [27]. Both adhesion
(Fig. 2A and C). However, this increase was transient, molecules have been described to be rapidly upregulated
probably due to the retention of the most activated on platelets upon stimulation [26,27]. We have found both
leukocytes in the tubing and the oxygenator of the CPB. markers to be upregulated systemically throughout reperfu-
The transcardiac difference for CD11b on PMN and sion, with a peak after protamine application (Fig. 4A and
(tendencially) on monocytes was negative during the first C). Furthermore, we investigated whether global myocar-
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dial reperfusion after cardioplegia leads to a specific to other organs, has by far the most important conse-
activation of platelets during coronary passage. Surprising- quences for the clinical outcome of cardiothoracic surgery.
ly, mean veno–arterial differences of both P-selectin and
gpIIb / IIIa tended to be negative during early reperfusion. 4.5. Pathophysiological implications
This would suggest retention of activated platelets in the
coronary system rather than washout of activated throm- In the present study we found signs of very rapid
bocytes. In the 5th min of reperfusion, the negative veno– postischemic cardiac inflammation. In the first minutes of
arterial difference of platelet counts (Table 2, not signifi- reperfusion, a net trans-coronary increase of IL6 and
cant) strengthens this hypothesis. sequestration of activated neutrophils and of leukocyte–
The clear retention of platelets in the coronary system platelet coaggregates occurred in the coronary system. A
after administration of protamine (Table 2) correlates with second wave of these inflammatory responses took place at
a transient decrease of veno–arterial CD41 and CD62 later time points, namely with the application of protamine
levels (Fig. 4). In a later phase of reperfusion (75 min, and after onset of reperfusion of the fresh grafts. This time
about 40 min after the onset of blood passage through the course suggests that reperfusion injury is a consequence of
new grafts), P-selectin was markedly upregulated by a positive feedback, initiated by early reperfusion. This
coronary passage, indicating platelet activation, and, per- early phase could induce expression of pro-inflammatory
haps, beginning of acute reocclusion (Fig. 4B). genes, and, thus, set the stage for later events. If coronary
retention of activated leukocytes and platelets during early
reperfusion really is the trigger for the subsequent
4.4. Leukocyte–platelet interaction pathophysiologic effects, patients might greatly profit from
anti-inflammatory and anti-platelet interventions during,
Over the last years awareness has grown that blood cell and early after cardiosurgery.
populations do not act independently, and that mutual The crucial point of future studies has to be, how far the
functional modulation is common. For example, platelets experimental findings on inflammatory parameters corre-
readily adhere to leukocytes, priming them for subsequent late with the individual clinical outcome after coronary
chemotactic stimulation [26,28]. The formation of such bypass surgery.
leukocyte–platelet coaggregates has been shown after
coronary angioplasty, and may even be a predictor for the
development of restenosis [14]. Also in the situation of Acknowledgements
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